ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2459
0,00%
Bitcoin
67.677,64
0,29%
Brent Oil
81,295
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Neon Therapeutics Inc (NTGN)

  7. Neon Therapeutics Inc (NTGN) Notícias

NTGN

Neon Therapeutics (NTGN)

Neon Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NTGN
DataHoraFonteTítuloCódigoCompanhia
18/05/202007:09Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:NTGNNeon Therapeutics Inc
06/05/202018:10Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:NTGNNeon Therapeutics Inc
06/05/202018:04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:NTGNNeon Therapeutics Inc
06/05/202017:47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTGNNeon Therapeutics Inc
06/05/202011:48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:NTGNNeon Therapeutics Inc
01/05/202009:39Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NTGNNeon Therapeutics Inc
30/04/202008:00GlobeNewswire Inc.Neon Therapeutics Announces Acceptance of European Clinical Trial Authorization Application for NEO-PTC-01NASDAQ:NTGNNeon Therapeutics Inc
29/04/202018:31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:NTGNNeon Therapeutics Inc
21/04/202017:31Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:NTGNNeon Therapeutics Inc
10/04/202020:45PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Neon Therapeutics, Inc.NASDAQ:NTGNNeon Therapeutics Inc
02/04/202018:00Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:NTGNNeon Therapeutics Inc
02/04/202010:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NTGNNeon Therapeutics Inc
31/03/202007:42GlobeNewswire Inc.BioNTech Announces Full Year 2019 Financial Results and Corporate UpdateNASDAQ:NTGNNeon Therapeutics Inc
25/03/202018:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTGNNeon Therapeutics Inc
23/03/202009:17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NTGNNeon Therapeutics Inc
02/03/202010:46Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NTGNNeon Therapeutics Inc
02/03/202010:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NTGNNeon Therapeutics Inc
02/03/202009:00GlobeNewswire Inc.Neon Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business UpdateNASDAQ:NTGNNeon Therapeutics Inc
14/02/202018:11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NTGNNeon Therapeutics Inc
27/01/202017:37Edgar (US Regulatory)Schedule 13gNASDAQ:NTGNNeon Therapeutics Inc
23/01/202018:02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:NTGNNeon Therapeutics Inc
23/01/202011:57PR Newswire (US)Moore Kuehn, PLLC Encourages NTGN, HXL, FSB, and WMGI Investors to Contact FirmNASDAQ:NTGNNeon Therapeutics Inc
16/01/202009:30GlobeNewswire Inc.BioNTech to acquire Neon to strengthen global leadership position in T cell therapiesNASDAQ:NTGNNeon Therapeutics Inc
18/12/201910:01GlobeNewswire Inc.Neon Therapeutics Submits European Clinical Trial Authorization Application for Personal Neoantigen-Targeted T Cell Therapy N...NASDAQ:NTGNNeon Therapeutics Inc
20/11/201918:05GlobeNewswire Inc.Neon Therapeutics Announces New Strategic Focus on Novel T Cell ProgramsNASDAQ:NTGNNeon Therapeutics Inc
12/11/201909:00GlobeNewswire Inc.Neon Therapeutics Reports Third Quarter 2019 Financial Results and Recent HighlightsNASDAQ:NTGNNeon Therapeutics Inc
08/11/201909:00GlobeNewswire Inc.Neon Therapeutics Announces Updated Data Presented at Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:NTGNNeon Therapeutics Inc
05/09/201917:01GlobeNewswire Inc.Neon Therapeutics Announces Publication in Immunity of Novel Approach to Predict MHC Class II Cancer-Specific NeoantigensNASDAQ:NTGNNeon Therapeutics Inc
06/08/201908:00GlobeNewswire Inc.Neon Therapeutics Reports Second Quarter 2019 Financial ResultsNASDAQ:NTGNNeon Therapeutics Inc
15/07/201910:04Dow Jones NewsNeon Therapeutics Vaccine Study Shows Prolonged Progression-Free SurvivalNASDAQ:NTGNNeon Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:NTGN

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
CIEL3
CIELO ON
BOV
PRIO3
PETRORIO ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
RCSL3
RECRUSUL ON
BOV
TECN3
TECHNOS ON
BOV
SGPS3
SPRINGS ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados